BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28535002)

  • 1. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
    Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
    Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
    Wang X; Guo H; Yao B; Helms J
    Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
    Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
    Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
    Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
    Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
    Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
    Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
    Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
    He B; Lin X; Tian F; Yu W; Qiao B
    J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.
    Shang A; Lu WY; Yang M; Zhou C; Zhang H; Cai ZX; Wang WW; Wang WX; Wu GQ
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1754-1762. PubMed ID: 29073835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA RP5-916L7.2 correlates with advanced tumor stage, and promotes cells proliferation while inhibits cells apoptosis through targeting miR-328 and miR-939 in tongue squamous cell carcinoma.
    Chen Y; Guo Y; Yan W
    Clin Biochem; 2019 May; 67():24-32. PubMed ID: 30825424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2.
    Sun X; Zhang L
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28174335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.